
|Podcasts|April 9, 2021
Podcast: Visus presbyopia drop gets FDA IND OK
A presbyopia-correcting eyedrop recently received FDA acceptance of its investigational new drug (IND) application
Advertisement
Rhett Schiffman, MD, MHSA, chief medical officer and head of research and development at Visus Therapeutics, talks with Gretchyn Bailey, NCLC, FAAO, editor in chief of Optometry Times® about Brimichol, the company’s presbyopia-correcting eyedrop that recently received FDA acceptance of its investigational new drug (IND) application.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Bausch + Lomb launches preservative-free version of Blink Triple Care eye drops
2
Exercise for the prevention and mitigation of eye disease
3
Georgia university receives state funding for state's first college of optometry
4
Recent study findings may prove previous estimations of retinal cell communication, low-light vision
5





















